#USA #Los Angeles #Schall Law Firm #Securities Fraud #uniQure N.V.

Potential Opportunity for uniQure Investors

In a significant legal development, the Schall Law Firm, a prominent national firm specializing in shareholder rights litigation, has recently highlighted a class action lawsuit aimed at uniQure N.V. (NASDAQ: QURE). This lawsuit stems from alleged violations of sections 10(b) and 20(a) of the Securities Exchange Act of 1934, along with Rule 10b-5 as established by the U.S. Securities and Exchange Commission (SEC). The firm reminds individuals who purchased uniQure's securities between September 24, 2025, and October 31, 2025, to reach out before the approaching deadline of April 13, 2026, to better understand their potential claims.

Understanding the Allegations

According to the official complaint, uniQure is accused of making several misleading statements that adversely affected the investment community. The primary allegation revolves around the company’s inability to secure full FDA approval for its pivotal study, which was expected to play a crucial role in its product's market launch. It seems that uniQure misled stakeholders regarding the regulatory approval timeline, particularly concerning the critical Biologics License Application (BLA) it submitted for review. As a result, investors were left in the dark about the reality surrounding the approval process.

Why This Matters to Investors

When the truth regarding uniQure's situation came to light, investors suffered significant financial losses. It is essential for stakeholders affected during the aforementioned class period to recognize their rights and consider joining this lawsuit, as the Schall Law Firm has made it clear that participation could potentially lead to compensation for their losses.

How to Get Involved

If you believe you are eligible and wish to participate, the Schall Law Firm encourages you to contact them for a free consultation. Investors can reach Brian Schall directly at their Los Angeles office, or through their website for further guidance on the steps involved in joining the class action. It is critical to note that the class has not yet been certified, meaning that those who choose not to take action will not be represented by legal counsel in this matter.

Join Now for Your Rights

The Schall Law Firm has established a strong reputation for representing investors globally, particularly through securities class action lawsuits. Their commitment to protecting shareholder rights is evident in their proactive outreach to affected individuals. In the face of potential financial turmoil, affected investors are urged to consider the implications of remaining passive versus taking proactive steps to secure their rights within the class action system.

In summation, this lawsuit represents an opportunity for stakeholders in uniQure N.V. to reclaim losses incurred during a tumultuous period for the company. Engage with the Schall Law Firm to investigate your options and make an informed decision about your potential role in this significant legal action. For additional inquiries, feel free to connect via the law firm's official communication channels.